LATEST ARTICLES
- Merck inks deal with Sinopharm to commercialize COVID-19 pills in China
- Sanofi expects major boost from foreign currency fluctuations in third quarter
- Eli Lilly hit with another age discrimination lawsuit—this time from a federal agency
- Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden’s pricing bill: analysts
- Temperature Controlled Logistics in Biopharmaceuticals Europe 2023
